Skip to main content

Tezepelumab News

Tezepelumab Reduces Mucus Plugs in Adults With Uncontrolled Asthma

FRIDAY, Sept. 29, 2023 – Tezepelumab is associated with a reduction in occlusive mucus plugs versus placebo in adults with uncontrolled asthma, according to a study published in the October issue of...

Tezspire Approved for Self-Administration in the U.S. With a New Pre-filled Pen

Now Offers Patients the Choice of Administration at Home or in a Doctor's Office THOUSAND OAKS, Calif., Feb. 2, 2023 /PRNewswire/ – Amgen (NASDAQ:AMGN) and AstraZeneca today announced the U.S....

FDA Approves Tezspire (tezepelumab) for Severe Asthma

17 December 2021 – AstraZeneca and Amgen’s Tezspire (tezepelumab-ekko) has been approved in the US for the add-on maintenance treatment of adult and paediatric patients aged 12 years and older with s...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Asthma

Tezepelumab patient information at Drugs.com